Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Aug;20(8):1969-1983.
doi: 10.1111/ajt.16002. Epub 2020 Jun 17.

A comprehensive review of the impact of tacrolimus intrapatient variability on clinical outcomes in kidney transplantation

Haley M Gonzales  1 , John W McGillicuddy  1 , Vinayak Rohan  1 , Jessica L Chandler  2 , Satish N Nadig  1 , Derek A Dubay  1 , David J Taber  1
Affiliations
Review

A comprehensive review of the impact of tacrolimus intrapatient variability on clinical outcomes in kidney transplantation

Haley M Gonzales et al. Am J Transplant. 2020 Aug.

Abstract

Tacrolimus (Tac) is widely used to prevent rejection and graft loss in solid organ transplantation. A limiting characteristic of Tac is the high intra and interpatient variability associated with its use. Routine therapeutic drug monitoring (TDM) is necessary to facilitate Tac management and to avoid undesirable clinical outcomes. However, whole blood trough concentrations commonly utilized in TDM are not strong predictors of the detrimental clinical outcomes of interest. Recently, researchers have focused on Tac intrapatient variability (Tac IPV) as a novel marker to better assess patient risk. Higher Tac IPV has been associated with a number of mechanisms leading to shortened graft survival. Medication nonadherence (MNA) is considered to be the primary determinant of high Tac IPV and perhaps the most modifiable risk factor. An understanding of the methodology behind Tac IPV is imperative to its recognition as an important prognostic measure and integration into clinical practice. Therapeutic interventions targeting MNA and reducing Tac IPV are crucial to improving long-term graft survival.

Keywords: graft survival; health services and outcomes research; immunosuppressant - calcineurin inhibitor: tacrolimus; kidney transplantation/nephrology.

PubMed Disclaimer

Conflict of interest statement

DISCLOSURE

The authors have no conflicts of interest to disclose as described by the American Journal of Transplantation.

Figures

FIGURE 1
FIGURE 1
Conceptual model of high tacrolimus (Tac) intrapatient variability (IPV) and graft loss in kidney transplant recipients. The key determinants of high Tac variability are food and drug interactions, including herbal supplements, genetic factors, medication nonadherence, and concomitant illness. High Tac variability leads to an increased incidence of acute rejection, de novo donor-specific antibody (dnDSA) development, and histologic lesions. Ultimately, there is an increased risk of graft loss in recipients with high Tac IPV
See this image and copyright information in PMC

References

    1. Hart A, Smith JM, Skeans MA, et al. OPTN/SRTR 2017 annual data report: kidney. Am J Transplant. 2019;19(S2):19–123. - PubMed
    1. Staatz CE, Tett SE. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation. Clin Pharmacokinet. 2004;43(10):623–653. - PubMed
    1. McGillicuddy JW, Sox L, Chandler J, Treiber F, Taber D. Impact of an mHealth, electronic pillbox intervention on tacrolimus variability in kidney transplantation: results of a prospective randomized clinical trial [abstract]. Am J Transplant. 2019;19;(suppl:3):1149–1150.
    1. Shuker N, van Gelder T, Hesselink DA. Intra-patient variability in tacrolimus exposure: causes, consequences for clinical management. Transplant Rev. 2015;29(2):78–84. - PubMed
    1. Ro H, Min S-I, Yang J, et al. Impact of tacrolimus intraindividual variability and CYP3A5 genetic polymorphism on acute rejection in kidney transplantation. Ther Drug Monit. 2012;34(6):680–685. - PubMed